Result of Meeting

RNS Number : 4661K
Primary Health Properties PLC
04 January 2021
 

4 January 2021

Primary Health Properties PLC

("PHP" or the "Company")

Result of General Meeting

 

Further to the announcement on 10 December 2020 in relation to the proposed management internalisation and adoption of the New Articles, all of the resolutions put to shareholders required to effect the Internalisation and approve the adoption of the New Articles (as set out in full in the Notice of General Meeting issued on 11 December 2020) were duly passed.

Any proxy votes which were at the discretion of the Chairman have been included in the "For" total

Full details of the results are set out below.


Resolution

Votes For

%

Votes Against

%

Total Votes Validly Cast

Vote withheld

%

1. 

Approval of substantial property acquisition from Harry Hyman, allotment of shares and remuneration policy

759,002,089

99.95

416,356

0.05

781,849,853

22,431,408

2.87

2. 

Adoption of new articles of association

773,995,971

99.97

227,114

0.03

783,849,915

9,666,830

1.23

 

Shareholders representing 99.9% of the votes cast voted in favour of all the resolutions at the GM. Votes 'For' and 'Against' are expressed as a percentage of the total votes received. 'Votes Withheld' are not a vote in law and have not been counted in the calculation of the 'Votes For' and 'Votes Against' the resolutions or the total number of votes validly cast.

As at close of business on 30 December 2020, being the last for registration of shareholdings for before the General Meeting, PHP had 1,315,551,380 Ordinary Shares in issue each carrying one vote and therefore the total number of voting rights in respect of the General Meeting is 1,315,551,380. As set out in full in the Circular, Harry Hyman, who (together with persons closely associated with him) held 12,897,174 shares at the time of the General Meeting, voluntarily agreed not to vote on the Acquisition Resolution.

The voting results will also shortly be available on PHP's website at www.phpgroup.co.uk/investors .

Applications have been made to the Financial Conduct Authority (the "FCA") and the London Stock Exchange plc (the "LSE") respectively for the admission of 11,485,080 new Ordinary Shares ("New Shares") pursuant to the terms of the Share Purchase Agreement to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE (together, "Admission").

Admission of the New Shares is expected to be effective on 6 January 2021. Following admission and in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, the Company will have 1,327,036,460 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any shares in treasury.

The above figure of 1,327,036,460 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

Capitalised terms used but not defined in this announcement have the meanings given to them in the circular published by the Company on 11 December 2020.

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

For further information contact:

Primary Health Properties PLC

Steven Owen, Chairman

Paul Wright, Company Secretary

 

020 7451 7050  

Numis Securities Limited (Joint Sponsor, Financial Adviser and Broker)

James Black / Kevin Cruickshank / Huw Jeremy

 

020 7260 1000

Peel Hunt LLP (Joint Sponsor, Financial Adviser and Broker)

Capel Irwin / Carl Gough / Harry Nicholas

 

020 7418 8900

Buchanan

David Rydell / Steph Watson / Tilly Abraham 

0207 466 5066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMZZGGMZDVGMZM
UK 100